Showing 1 - 10 of 42,877
Biologic drugs represent an important category of drugs that improve health outcomes in this country. Yet, these cutting-edge drugs are often prohibitively costly, preventing access for many Americans. Recognizing the need for more affordable, generic substitutes for biologic drugs — or...
Persistent link: https://www.econbiz.de/10014148056
Since the late 1990s, opioids have been increasingly prescribed for pain treatment in the U.S as a result of aggressive marketing by pharmaceutical companies. This has resulted in more than 450,000 opioid overdose deaths since then. In the same time period, several U.S. states have legalized...
Persistent link: https://www.econbiz.de/10013322640
In this paper, we argue that lower prices for pharmaceuticals can be achieved by fostering a new type of competition in …
Persistent link: https://www.econbiz.de/10014060120
.This chapter will provide an overview of free movement cases on pharmaceuticals, with a view to frame such case law within the … section will provide an overview of the structure of the European market for pharmaceuticals, including the basic European … regulatory framework; a second section will review the case law on free movement and pharmaceuticals; and a last section will …
Persistent link: https://www.econbiz.de/10012980141
Governments and firms often use committees of experts to help them make complexdecisions, but conflicts of interest could bias experts' recommendations. We focus on whetherfinancial ties to drug companies bias FDA drug advisory committee (AC) members' voting ondrug approval recommendations. We...
Persistent link: https://www.econbiz.de/10012934325
Drug shortages are emerging as a major public health threat. Grave concern has been expressed by the medical community and government officials, and the crisis has been highlighted in recent media stories. Nevertheless, little has been written to date in the legal literature about the drug...
Persistent link: https://www.econbiz.de/10014173190
Governments worldwide are increasingly concerned about the booming CBD (cannabidiol) products. However, little is known about the impact of their liberalization. We study a unique case of unintended liberalization of a CBD-based product (light cannabis) that occurred in Italy in 2017. Using...
Persistent link: https://www.econbiz.de/10012183060
Governments worldwide are increasingly concerned about the booming CBD (cannabidiol) products. However, little is known about the impact of their liberalization. We study a unique case of unintended liberalization of a CBD-based product (light cannabis) that occurred in Italy in 2017. Using...
Persistent link: https://www.econbiz.de/10012839052
In response to the opioid crisis, US states have implemented policies to reduce the dispensingof opioids and curb drug mortality. Exploiting a long panel of county-level data, weanalyse the combination of demand- and supply-side state opioid policies and evaluate theirintended effects on opioids...
Persistent link: https://www.econbiz.de/10012847953
Twenty-three states and the District of Columbia have passed medical marijuana laws. Previous research shows that these laws increase marijuana use among adults. In this paper, we estimate the effects of medical marijuana laws (MML) on secondary and post-secondary students' time use using time...
Persistent link: https://www.econbiz.de/10011457919